NewsFeed
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Chaithra S K: Preimplantation Genetic Testing Still Requires an Embryo Biopsy
Oct 29, 2026, 16:15

Chaithra S K: Preimplantation Genetic Testing Still Requires an Embryo Biopsy

Chaithra S K, Medical Director at Ovum Fertility, shared on LinkedIn:

“Preimplantation genetic testing still requires an embryo biopsy. For many patients, that is the part of the cycle that causes the most anxiety.

Which makes non-invasive PGT worth watching.

Conventional PGT-A means removing a few cells from the blastocyst to assess its chromosomes. In experienced hands, it is safe and valuable — but it is technically demanding, and understandably unsettling for the people it’s performed on.

Non-invasive PGT takes a different route. As an embryo develops, it releases cell-free DNA into its culture medium, and the idea is to analyse that rather than biopsy the embryo directly. A gentler, simpler, potentially more affordable test.

The caution is equally real. Concordance with conventional biopsy is not yet consistent, and contaminating DNA remains a genuine problem. For now it is an emerging tool, not a validated replacement.

What interests me is the direction it points in – less invasive, more patient-friendly diagnostics across the field.

The question isn’t whether non-invasive testing arrives. It’s how carefully we validate it before patients are asked to rely on it. In a market that adopts new add-ons quickly, who holds that line?

Proceed to the video attached to the post.

Other articles featuring Chaithra S K on Fertility News.